Nutrigenetics and metabolic disease: Current status and implications for personalised nutrition

Nutrients

Volumn 5, Issue 1, 2013, Pages 32-57

  Phillips, Catherine M ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Diabetes; Dietary fat; Gene nutrient interaction; Insulin resistance; Metabolic health; Metabolic syndrome; Metabotype; Nutrigenetics; Obesity

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ADIPONECTIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CALPAIN 10; COMPLEMENT COMPONENT C3; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEPTIN RECEPTOR; LONG CHAIN ACYL COA SYNTHETASE 1; LONG CHAIN FATTY ACID COENZYME A LIGASE; LYMPHOTOXIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; STAT3 PROTEIN; TRANSCRIPTION FACTOR 7 LIKE 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADIPONECTIN GENE; ALLELE; CALPAIN 10 GENE; DISEASE ASSOCIATION; DYSLIPIDEMIA; FAT INTAKE; FAT MASS AND OBESITY ASSOCIATED GENE; FATTY ACID METABOLISM; GENE; GENE IDENTIFICATION; GENE LOCUS; GENE NUTRIENT INTERACTION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; INSULIN SENSITIVITY; LIPID METABOLISM; METABOLIC SYNDROME X; MONOGENIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRIGENETICS; NUTRIGENOMICS; OBESITY; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA GENE; PERSONALIZED MEDICINE; PHENYLKETONURIA; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION FACTOR 7 LIKE 2 GENE;

EID: 84872853014     PISSN: 20726643     EISSN: None     Source Type: Journal    
DOI: 10.3390/nu5010032     Document Type: Review

References (133)

1. Moller, D.E. Kaufman, K.D. Metabolic syndrome: A clinical and molecular perspective. Annu. Rev. Med. 2005, 56, 45-62.
2. Alberti, K.G. Zimmet, P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a who consultation. Diabet. Med. 1998, 15, 539-553.
3. Balkau, B. Charles, M.A. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet. Med. 1999, 16, 442-443.
4. National Cholesterol Education Program National Heart, Lung, and Blood Institute National Institutes of Health. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002, 106, 3143-3421.
5. Alberti, K.G. Zimmet, P. Shaw, J. The metabolic syndrome-A new worldwide definition. Lancet 2005, 366, 1059-1062.
6. Alberti, K.G. Eckel, R.H. Grundy, S.M. Zimmet, P.Z. Cleeman, J.I. Donato, K.A. Fruchart, J.C. James, W.P. Loria, C.M. Smith, S.C., Jr. Harmonizing the metabolic syndrome: A joint interim statement of the international diabetes federation task force on epidemiology and prevention national heart, lung, and blood institute american heart association world heart federation international atherosclerosis society and international association for the study of obesity. Circulation 2009, 120, 1640-1645.
7. Ford, E.S. Li, C. Zhao, G. Prevalence and correlates of metabolic syndrome based on a harmonious definition among adults in the US. J. Diabetes 2010, 2, 180-193.
8. Flier, J.S. Obesity wars: Molecular progress confronts an expanding epidemic. Cell 2004, 116, 337-350.
9. Anderson, J.W. Kendall, C.W. Jenkins, D.J. Importance of weight management in type 2 diabetes: Review with meta-analysis of clinical studies. J. Am. Coll. Nutr. 2003, 22, 331-339.
10. Shaw, J.E. Sicree, R.A. Zimmet, P.Z. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res. Clin. Pract. 2010, 87, 4-14.
11. Bellia, A. Giardina, E. Lauro, D. Tesauro, M. Di Fede, G. Cusumano, G. Federici, M. Rini, G.B. Novelli, G. Lauro, R. et al. The linosa study: Epidemiological and heritability data of the metabolic syndrome in a caucasian genetic isolate. Nutr. Metab. Cardiovasc. Dis. 2009, 19, 455-461.
12. Henneman, P. Aulchenko, Y.S. Frants, R.R. van Dijk, K.W. Oostra, B.A. van Duijn, C.M. Prevalence and heritability of the metabolic syndrome and its individual components in a dutch isolate: The erasmus rucphen family study. J. Med. Genet. 2008, 45, 572-577.
13. Eckel, R.H. Grundy, S.M. Zimmet, P.Z. The metabolic syndrome. Lancet 2005, 365, 1415-1428.
14. Lottenberg, A.M. Afonso Mda, S. Lavrador, M.S. Machado, R.M. Nakandakare, E.R. The role of dietary fatty acids in the pathology of metabolic syndrome. J. Nutr. Biochem. 2012, 23, 1027-1040.
15. Phillips, C. Lopez-Miranda, J. Perez-Jimenez, F. McManus, R. Roche, H.M. Genetic and nutrient determinants of the metabolic syndrome. Curr. Opin. Cardiol. 2006, 21, 185-193.
16. Szabo de Edelenyi, F. Goumidi, L. Bertrais, S. Phillips, C. Macmanus, R. Roche, H. Planells, R. Lairon, D. Prediction of the metabolic syndrome status based on dietary and genetic parameters, using random forest. Genes Nutr. 2008, 3, 173-176.
17. Vessby, B. Dietary fat, fatty acid composition in plasma and the metabolic syndrome. Curr. Opin. Lipidol. 2003, 14, 15-19.
18. Warensjo, E. Sundstrom, J. Lind, L. Vessby, B. Factor analysis of fatty acids in serum lipids as a measure of dietary fat quality in relation to the metabolic syndrome in men. Am. J. Clin. Nutr. 2006, 84, 442-448.
19. Hu, F.B. van Dam, R.M. Liu, S. Diet and risk of Type II diabetes: The role of types of fat and carbohydrate. Diabetologia 2001, 44, 805-817.
20. Melanson, E.L. Astrup, A. Donahoo, W.T. The relationship between dietary fat and fatty acid intake and body weight, diabetes, and the metabolic syndrome. Ann. Nutr. Metab. 2009, 55, 229-243.
21. Meyer, K.A. Kushi, L.H. Jacobs, D.R., Jr. Folsom, A.R. Dietary fat and incidence of type 2 diabetes in older iowa women. Diabetes Care 2001, 24, 1528-1535.
22. Perez-Jimenez, F. Lopez-Miranda, J. Pinillos, M.D. Gomez, P. Paz-Rojas, E. Montilla, P. Marin, C. Velasco, M.J. Blanco-Molina, A. Jimenez Pereperez, J.A. et al. A mediterranean and a high-carbohydrate diet improve glucose metabolism in healthy young persons. Diabetologia 2001, 44, 2038-2043.
23. Tierney, A.C. McMonagle, J. Shaw, D.I. Gulseth, H.L. Helal, O. Saris, W.H. Paniagua, J.A. Golabek-Leszczynska, I. Defoort, C. Williams, C.M. et al. Effects of dietary fat modification on insulin sensitivity and on other risk factors of the metabolic syndrome-LIPGENE: A european randomized dietary intervention study. Int. J. Obes. (Lond.) 2011, 35, 800-809.
24. Due, A. Larsen, T.M. Mu, H. Hermansen, K. Stender, S. Astrup, A. Comparison of 3 ad libitum diets for weight-loss maintenance, risk of cardiovascular disease, and diabetes: A 6-mo randomized, controlled trial. Am. J. Clin. Nutr. 2008, 88, 1232-1241.
25. Due, A. Larsen, T.M. Hermansen, K. Stender, S. Holst, J.J. Toubro, S. Martinussen, T. Astrup, A. Comparison of the effects on insulin resistance and glucose tolerance of 6-mo high-monounsaturated-fat, low-fat, and control diets. Am. J. Clin. Nutr. 2008, 87, 855-862.
26. Vessby, B. Unsitupa, M. Hermansen, K. Riccardi, G. Rivellese, A.A. Tapsell, L.C. Nalsen, C. Berglund, L. Louheranta, A. Rasmussen, B.M. et al. Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The kanwu study. Diabetologia 2001, 44, 312-319.
27. Oliver, E. McGillicuddy, F.C. Harford, K.A. Reynolds, C.M. Phillips, C.M. Ferguson, J.F. Roche, H.M. Docosahexaenoic acid attenuates macrophage-induced inflammation and improves insulin sensitivity in adipocytes-specific differential effects between LC n-3 PUFA. J. Nutr. Biochem. 2011, 23, 1192-1200.
28. Storlien, L.H. Baur, L.A. Kriketos, A.D. Pan, D.A. Cooney, G.J. Jenkins, A.B. Calvert, G.D. Campbell, L.V. Dietary fats and insulin action. Diabetologia 1996, 39, 621-631.
29. Storlien, L.H. Jenkins, A.B. Chisholm, D.J. Pascoe, W.S. Khouri, S. Kraegen, E.W. Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and omega-3 fatty acids in muscle phospholipid. Diabetes 1991, 40, 280-289.
30. Willett, W. Nutritional Epidemiology, 2nd ed. Oxford University Press: New York, NY, USA, 1998.
31. Perez-Martinez, P. Phillips, C.M. Delgado-Lista, J. Garcia-Rios, A. Lopez-Miranda, Francisco Perez-Jimenez, J. Nutrigenetics, Metabolic syndrome risk and personalized nutrition. Curr. Vasc. Pharmacol. 2012, in press.
32. Phillips, C.M. Tierney, A.C. Roche, H.M. Gene-nutrient interactions in the metabolic syndrome. J. Nutrigenet. Nutrigenomics 2008, 1, 136-151.
33. Roche, H.M. Phillips, C. Gibney, M.J. The metabolic syndrome: The crossroads of diet and genetics. Proc. Nutr. Soc. 2005, 64, 371-377.
34. Allison, D.B. Faith, M.S. Nathan, J.S. Risch's lambda values for human obesity. Int. J. Obes. Relat. Metab. Disord. 1996, 20, 990-999.
35. Maes, H.H. Neale, M.C. Eaves, L.J. Genetic and environmental factors in relative body weight and human adiposity. Behav. Genet. 1997, 27, 325-351.
36. Stunkard, A.J. Sorensen, T.I. Hanis, C. Teasdale, T.W. Chakraborty, R. Schull, W.J. Schulsinger, F. An adoption study of human obesity. N. Engl. J. Med. 1986, 314, 193-198.
37. Bouchard, C. Perusse, L. Leblanc, C. Tremblay, A. Theriault, G. Inheritance of the amount and distribution of human body fat. Int. J. Obes. 1988, 12, 205-215.
38. Vogler, G.P. Sorensen, T.I. Stunkard, A.J. Srinivasan, M.R. Rao, D.C. Influences of genes and shared family environment on adult body mass index assessed in an adoption study by a comprehensive path model. Int. J. Obes. Relat. Metab. Disord. 1995, 19, 40-45.
39. Florez, J.C. Hirschhorn, J. Altshuler, D. The inherited basis of diabetes mellitus: Implications for the genetic analysis of complex traits. Annu. Rev. Genomics. Hum. Genet. 2003, 4, 257-291.
40. Gloyn, A.L. The search for type 2 diabetes genes. Ageing Res. Rev. 2003, 2, 111-127.
41. Andreasen, C.H. Andersen, G. Gene-environment interactions and obesity-Further aspects of genomewide association studies. Nutrition 2009, 25, 998-1003.
42. Horikawa, Y. Oda, N. Cox, N.J. Li, X. Orho-Melander, M. Hara, M. Hinokio, Y. Lindner, T.H. Mashima, H. Schwarz, P.E et al Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat. Genet. 2000, 26, 163-175.
43. Saez, M.E. Gonzalez-Sanchez, J.L. Ramirez-Lorca, R. Martinez-Larrad, M.T. Zabena, C. Gonzalez, A. Moron, F.J. Ruiz, A. Serrano-Rios, M. The CAPN10 gene is associated with insulin resistance phenotypes in the Spanish population. PLoS One 2008, 3, e2953.
44. Carlsson, E. Fredriksson, J. Groop, L. Ridderstrale, M. Variation in the calpain-10 gene is associated with elevated triglyceride levels and reduced adipose tissue messenger ribonucleic acid expression in obese Swedish subjects. J. Clin. Endocrinol. Metab. 2004, 89, 3601-3605.
45. Garant, M.J. Kao, W.H. Brancati, F. Coresh, J. Rami, T.M. Hanis, C.L. Boerwinkle, E. Shuldiner, A.R. SNP43 of CAPN10 and the risk of type 2 diabetes in African-Americans: The atherosclerosis risk in communities study. Diabetes 2002, 51, 231-237.
46. Shima, Y. Nakanishi, K. Odawara, M. Kobayashi, T. Ohta, H. Association of the SNP-19 genotype 22 in the calpain-10 gene with elevated body mass index and hemoglobin A1c levels in Japanese. Clin. Chim. Acta 2003, 336, 89-96.
47. Florez, J.C. Jablonski, K.A. Bayley, N. Pollin, T.I. de Bakker, P.I. Shuldiner, A.R. Knowler, W.C. Nathan, D.M. Altshuler, D. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N. Engl. J. Med. 2006, 355, 241-250.
48. Grant, S.F. Thorleifsson, G. Reynisdottir, I. Benediktsson, R. Manolescu, A. Sainz, J. Helgason, A. Stefansson, H. Emilsson, V. Helgadottir, A. et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat. Genet. 2006, 38, 320-323.
49. Cauchi, S. El Achhab, Y. Choquet, H. Dina, C. Krempler, F. Weitgasser, R. Nejjari, C. Patsch, W. Chikri, M. Meyre, D. et al. TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: A global meta-analysis. J. Mol. Med. (Berl.) 2007, 85, 777-782.
50. Cauchi, S. Meyre, D. Dina, C. Choquet, H. Samson, C. Gallina, S. Balkau, B. Charpentier, G. Pattou, F. Stetsyuk, V. et al. Transcription factor TCF7L2 genetic study in the french population: Expression in human beta-cells and adipose tissue and strong association with type 2 diabetes. Diabetes 2006, 55, 2903-2908.
51. Chandak, G.R. Janipalli, C.S. Bhaskar, S. Kulkarni, S.R. Mohankrishna, P. Hattersley, A.T. Frayling, T.M. Yajnik, C.S. Common variants in the TCF7L2 gene are strongly associated with type 2 diabetes mellitus in the indian population. Diabetologia 2007, 50, 63-67.
52. Hayashi, T. Iwamoto, Y. Kaku, K. Hirose, H. Maeda, S. Replication study for the association of TCF7L2 with susceptibility to type 2 diabetes in a japanese population. Diabetologia 2007, 50, 980-984.
53. Humphries, S.E. Gable, D. Cooper, J.A. Ireland, H. Stephens, J.W. Hurel, S.J. Li, K.W. Palmen, J. Miller, M.A. Cappuccio, F.P. et al. Common variants in the TCF7L2 gene and predisposition to type 2 diabetes in UK European whites, Indian Asians and Afro-Caribbean men and women. J. Mol. Med. (Berl.) 2006, 84, 1005-1014.
54. Wang, J. Kuusisto, J. Vanttinen, M. Kuulasmaa, T. Lindstrom, J. Tuomilehto, J. Uusitupa, M. Laakso, M. Variants of transcription factor 7-like 2 (TCF7L2) gene predict conversion to type 2 diabetes in the finnish diabetes prevention study and are associated with impaired glucose regulation and impaired insulin secretion. Diabetologia 2007, 50, 1192-1200.
55. Melzer, D. Murray, A. Hurst, A.J. Weedon, M.N. Bandinelli, S. Corsi, A.M. Ferrucci, L. Paolisso, G. Guralnik, J.M. Frayling, T.M. Effects of the diabetes linked TCF7L2 polymorphism in a representative older population. BMC Med. 2006, 4, 34.
56. Warodomwichit, D. Arnett, D.K. Kabagambe, E.K. Tsai, M.Y. Hixson, J.E. Straka, R.J. Province, M. An, P. Lai, C.Q. Borecki, I. et al. Polyunsaturated fatty acids modulate the effect of TCF7L2 gene variants on postprandial lipemia. J. Nutr. 2009, 139, 439-446.
57. Sjogren, M. Lyssenko, V. Jonsson, A. Berglund, G. Nilsson, P. Groop, L. Orho-Melander, M. The search for putative unifying genetic factors for components of the metabolic syndrome. Diabetologia 2008, 51, 2242-2251.
58. Marzi, C. Huth, C. Kolz, M. Grallert, H. Meisinger, C. Wichmann, H.E. Rathmann, W. Herder, C. Illig, T. Variants of the transcription factor 7-like 2 gene (TCF7L2) are strongly associated with type 2 diabetes but not with the metabolic syndrome in the MONICA/KORA surveys. Horm. Metab. Res. 2007, 39, 46-52.
59. Saadi, H. Nagelkerke, N. Carruthers, S.G. Benedict, S. Abdulkhalek, S. Reed, R. Lukic, M. Nicholls, M.G. Association of TCF7L2 polymorphism with diabetes mellitus, metabolic syndrome, and markers of beta cell function and insulin resistance in a population-based sample of emirati subjects. Diabetes Res. Clin. Pract. 2008, 80, 392-398.
60. Phillips, C.M. Goumidi, L. Bertrais, S. Field, M.R. McManus, R. Hercberg, S. Lairon, D. Planells, R. Roche, H.M. Dietary saturated fat, gender and genetic variation at the TCF7L2 locus predict the development of metabolic syndrome. J. Nutr. Biochem. 2012, 23, 239-244.
61. Povel, C.M. Boer, J.M. Reiling, E. Feskens, E.J. Genetic variants and the metabolic syndrome: A systematic review. Obes. Rev. 2011, 12, 952-967.
62. Frayling, T.M. Timpson, N.J. Weedon, M.N. Zeggini, E. Freathy, R.M. Lindgren, C.M. Perry, J.R. Elliott, K.S. Lango, H. Rayner, N.W. et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007, 316, 889-894.
63. Haupt, A. Thamer, C. Staiger, H. Tschritter, O. Kirchhoff, K. Machicao, F. Haring, H.U. Stefan, N. Fritsche, A. Variation in the FTO gene influences food intake but not energy expenditure. Exp. Clin. Endocrinol. Diabetes 2009, 117, 194-197.
64. Speakman, J.R. Rance, K.A. Johnstone, A.M. Polymorphisms of the fto gene are associated with variation in energy intake, but not energy expenditure. Obesity (Silver Spring) 2008, 16, 1961-1965.
65. Tanofsky-Kraff, M. Han, J.C. Anandalingam, K. Shomaker, L.B. Columbo, K.M. Wolkoff, L.E. Kozlosky, M. Elliott, C. Ranzenhofer, L.M. Roza, C.A. et al. The FTO gene rs9939609 obesity-risk allele and loss of control over eating. Am. J. Clin. Nutr. 2009, 90, 1483-1488.
66. Dina, C. Meyre, D. Gallina, S. Durand, E. Korner, A. Jacobson, P. Carlsson, L.M. Kiess, W. Vatin, V. Lecoeur, C. et al. Variation in FTO contributes to childhood obesity and severe adult obesity. Nat. Genet. 2007, 39, 724-726.
67. Hinney, A. Nguyen, T.T. Scherag, A. Friedel, S. Bronner, G. Muller, T.D. Grallert, H. Illig, T. Wichmann, H.E. Rief, W. et al. Genome wide association (GWA) study for early onset extreme obesity supports the role of fat mass and obesity associated gene (FTO) variants. PLoS One 2007, 2, e1361.
68. Hunt, S.C. Stone, S. Xin, Y. Scherer, C.A. Magness, C.L. Iadonato, S.P. Hopkins, P.N. Adams, T.D. Association of the FTO gene with BMI. Obesity (Silver Spring) 2008, 16, 902-904.
69. Thorleifsson, G. Walters, G.B. Gudbjartsson, D.F. Steinthorsdottir, V. Sulem, P. Helgadottir, A. Styrkarsdottir, U. Gretarsdottir, S. Thorlacius, S. Jonsdottir, I. et al. Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nat. Genet. 2009, 41, 18-24.
70. Willer, C.J. Speliotes, E.K. Loos, R.J. Li, S. Lindgren, C.M. Heid, I.M. Berndt, S.I. Elliott, A.L. Jackson, A.U., Lamina C. et al. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat. Genet. 2009, 41, 25-34.
71. Dupuis, J. Langenberg, C. Prokopenko, I. Saxena, R. Soranzo, N. Jackson, A.U. Wheeler, E. Glazer, N.L. Bouatia-Naji, N. Gloyn, A.L. et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat. Genet. 2010, 42, 105-116.
72. Manning, A.K. Hivert, M.F. Scott, R.A. Grimsby, J.L. Bouatia-Naji, N. Chen, H. Rybin, D. Liu, C.T. Bielak, L.F. Prokopenko, I. et al. A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat. Genet. 2012, 44, 659-669.
73. Perez-Caballero, A.I. Alcala-Diaz, J.F. Perez-Martinez, P. Garcia-Rios, A. Delgado-Casado, N. Marin, C. Yubero-Serrano, E. Camargo, A. Caballero, J. Malagon, M.M. et al. Lipid metabolism after an oral fat test meal is affected by age-associated features of metabolic syndrome, but not by age. Atherosclerosis 2013, 226, 258-262.
74. Phillips, C. Murugasu, G. Owens, D. Collins, P. Johnson, A. Tomkin, G.H. Improved metabolic control reduces the number of postprandial apolipoprotein B-48-containing particles in Type 2 diabetes. Atherosclerosis 2000, 148, 283-291.
75. Perez-Martinez, P. Delgado-Lista, J. Perez-Jimenez, F. Lopez-Miranda, J. Update on genetics of postprandial lipemia. Atheroscler. Suppl. 2010, 11, 39-43.
76. Perez-Martinez, P. Lopez-Miranda, J. Perez-Jimenez, F. Ordovas, J.M. Influence of genetic factors in the modulation of postprandial lipemia. Atheroscler. Suppl. 2008, 9, 49-55.
77. Deeb, S.S. Fajas, L. Nemoto, M. Pihlajamaki, J. Mykkanen, L. Kuusisto, J. Laakso, M. Fujimoto, W. Auwerx, J. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat. Genet. 1998, 20, 284-287.
78. Altshuler, D. Hirschhorn, J.N. Klannemark, M. Lindgren, C.M. Vohl, M.C. Nemesh, J. Lane, C.R. Schaffner, S.F. Bolk, S. Brewer, C. et al. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat. Genet. 2000, 26, 76-80.
79. Andrulionyte, L. Zacharova, J. Chiasson, J.L. Laakso, M. Common polymorphisms of the PPAR-gamma2 (Pro12Ala) and PGC-1alpha (Gly482Ser) genes are associated with the conversion from impaired glucose tolerance to type 2 diabetes in the STOP-NIDDM trial. Diabetologia 2004, 47, 2176-2184.
80. Ghoussaini, M. Meyre, D. Lobbens, S. Charpentier, G. Clement, K. Charles, M.A. Tauber, M. Weill, J. Froguel, P. Implication of the Pro12Ala polymorphism of the PPAR-gamma 2 gene in type 2 diabetes and obesity in the French population. BMC Med. Genet. 2005, 6, doi:10.1186/1471-2350-6-11.
81. Garcia-Rios, A. Delgado-Lista, J. Perez-Martinez, P. Phillips, C.M. Ferguson, J.F. Gjelstad, I.M. Williams, C.M. Karlstrom, B. Kiec-Wilk, B. Blaak, E.E. et al. Genetic variations at the lipoprotein lipase gene influence plasma lipid concentrations and interact with plasma n-6 polyunsaturated fatty acids to modulate lipid metabolism. Atherosclerosis 2011, 218, 416-422.
82. Phillips, C.M. Goumidi, L. Bertrais, S. Field, M.R. Cupples, L.A. Ordovas, J.M. Defoort, C. Lovegrove, J.A. Drevon, C.A. Gibney, M.J. et al. Gene-nutrient interactions with dietary fat modulate the association between genetic variation of the ACSL1 gene and metabolic syndrome. J. Lipid Res. 2010, 51, 1793-1800.
83. Phillips, C.M. Goumidi, L. Bertrais, S. Field, M.R. Cupples, L.A. Ordovas, J.M. McMonagle, J. Defoort, C. Lovegrove, J.A. Drevon, C.A. et al. ACC2 gene polymorphisms, metabolic syndrome, and gene-nutrient interactions with dietary fat. J. Lipid Res. 2010, 51, 3500-3507.
84. Phillips, C.M. Goumidi, L. Bertrais, S. Field, M.R. McManus, R. Hercberg, S. Lairon, D. Planells, R. Roche, H.M. Gene-nutrient interactions and gender may modulate the association between Apoa1 and Apob gene polymorphisms and metabolic syndrome risk. Atherosclerosis 2011, 214, 408-414.
85. Dalziel, B. Gosby, A.K. Richman, R.M. Bryson, J.M. Caterson, I.D. Association of the TNF-alpha-308 G/A promoter polymorphism with insulin resistance in obesity. Obes. Res. 2002, 10, 401-407.
86. Hamid, Y.H. Rose, C.S. Urhammer, S.A. Glumer, C. Nolsoe, R. Kristiansen, O.P. Mandrup-Poulsen, T. Borch-Johnsen, K. Jorgensen, T. Hansen, T. et al. Variations of the interleukin-6 promoter are associated with features of the metabolic syndrome in caucasian danes. Diabetologia 2005, 48, 251-260.
87. Huth, C. Heid, I.M. Vollmert, C. Gieger, C. Grallert, H. Wolford, J.K. Langer, B. Thorand, B. Klopp, N. Hamid, Y.H. et al. Il6 gene promoter polymorphisms and type 2 diabetes: Joint analysis of individual participants' data from 21 studies. Diabetes 2006, 55, 2915-2921.
88. Shen, J. Arnett, D.K. Perez-Martinez, P. Parnell, L.D. Lai, C.Q. Peacock, J.M. Hixson, J.E. Tsai, M.Y. Straka, R.J. Hopkins, P.N. et al. The effect of IL6-174C/G polymorphism on postprandial triglyceride metabolism in the GOLDN studyboxs. J. Lipid Res. 2008, 49, 1839-1845.
89. Sookoian, S. Garcia, S.I. Gianotti, T.F. Dieuzeide, G. Gonzalez, C.D. Pirola, C.J. The G-308A promoter variant of the tumor necrosis factor-alpha gene is associated with hypertension in adolescents harboring the metabolic syndrome. Am. J. Hypertens. 2005, 18, 1271-1275.
90. Meirhaeghe, A. Cottel, D. Amouyel, P. Dallongeville, J. Lack of association between certain candidate gene polymorphisms and the metabolic syndrome. Mol. Genet. Metab. 2005, 86, 293-299.
91. Qi, L., Zhang, C., van Dam, R.M., Hu, F.B. Interleukin-6 genetic variability and adiposity: Associations in two prospective cohorts and systematic review in 26,944 individuals. J. Clin. Endocrinol. Metab. 2007, 92, 3618-3625.
92. Phillips, C.M. Goumidi, L. Bertrais, S. Ferguson, J.F. Field, M.R. Kelly, E.D. Mehegan, J. Peloso, G.M. Cupples, L.A. Shen, J. et al. Additive effect of polymorphisms in the IL-6, LTA, and TNF-{alpha} genes and plasma fatty acid level modulate risk for the metabolic syndrome and its components. J. Clin. Endocrinol. Metab. 2010, 95, 1386-1394.
93. Aaronson, D.S. Horvath, C.M. A road map for those who don't know JAK-STAT. Science 2002, 296, 1653-1655.
94. Phillips, C.M. Goumidi, L. Bertrais, S. Field, M.R. Peloso, G.M. Shen, J. McManus, R. Hercberg, S. Lairon, D. Planells, R. et al. Dietary saturated fat modulates the association between STAT3 polymorphisms and abdominal obesity in adults. J. Nutr. 2009, 139, 2011-2017.
95. Weedon, M.N. McCarthy, M.I. Hitman, G. Walker, M. Groves, C.J. Zeggini, E. Rayner, N.W. Shields, B. Owen, K.R. Hattersley, A.T. et al. Combining information from common type 2 diabetes risk polymorphisms improves disease prediction. PLoS Med. 2006, 3, e374.
96. Engström, G. Hedblad, B. Eriksson, K.F. Janzon, L. Lindgärde, F. Complement C3 is a risk factor for the development of diabetes: A population-based cohort study. Diabetes 2005, 54, 570-575.
97. Halkes, C.J. van Dijk, H. de Jaegere, P.P. Plokker, H.W. van Der Helm, Y. Erkelens, D.W. Castro Cabezas, M. Postprandial increase of complement component 3 in normolipidemic patients with coronary artery disease: Effects of expanded-dose simvastatin. Arterioscler. Thromb. Vasc. Biol. 2001, 21, 1526-1530.
98. Muscari, A. Massarelli, G. Bastagli, L. Poggiopollini, G. Tomassetti, V. Drago, G. Martignani, C. Pacilli, P. Boni, P. Puddu, P. Relationship of serum C3 to fasting insulin, risk factors and previous ischaemic events in middle-aged men. Eur. Heart J. 2000, 21, 1081-1090.
99. Van Oostrom, A.J. Alipour, A. Plokker, T.W. Sniderman, A.D. Cabezas, M.C. The metabolic syndrome in relation to complement component 3 and postprandial lipemia in patients from an outpatient lipid clinic and healthy volunteers. Atherosclerosis 2007, 190, 167-173.
100. Phillips, C.M. Kesse-Guyot, E. Ahluwalia, N. McManus, R. Hercberg, S. Lairon, D. Planells, R. Roche, H.M. Dietary fat, abdominal obesity and smoking modulate the relationship between plasma complement component 3 concentrations and metabolic syndrome risk. Atherosclerosis 2012, 220, 513-519.
101. Phillips, C.M. Goumidi, L. Bertrais, S. Ferguson, J.F. Field, M.R. Kelly, E.D. Peloso, G.M. Cupples, L.A. Shen, J. Ordovas, J.M. et al. Complement component 3 polymorphisms interact with polyunsaturated fatty acids to modulate risk of metabolic syndrome. Am. J. Clin. Nutr. 2009, 90, 1665-1673.
102. Menzaghi, C. Trischitta, V. Doria, A. Genetic influences of adiponectin on insulin resistance, type 2 diabetes, and cardiovascular disease. Diabetes 2007, 56, 1198-1209.
103. Sheng, T. Yang, K. Adiponectin and its association with insulin resistance and type 2 diabetes. J. Genet. Genomics 2008, 35, 321-326.
104. Phillips, C.M. Goumidi, L. Bertrais, S. Field, M.R. Ordovas, J.M. Cupples, L.A. Defoort, C. Lovegrove, J.A. Drevon, C.A. Blaak, E.E. et al. Leptin receptor polymorphisms interact with polyunsaturated fatty acids to augment risk of insulin resistance and metabolic syndrome in adults. J. Nutr. 2010, 140, 238-244.
105. Neel, J.V. Diabetes mellitus: A thrifty genotype rendered detrimental by progress? Am. J. Hum. Genet. 1962, 14, 353-362.
106. Wild, S. Roglic, G. Green, A. Sicree, R. King, H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27, 1047-1053.
107. Esparza-Romero, J., Valencia, M.E., Martinez, M.E., Ravussin, E., Schulz, L.O., Bennett, P.H. Differences in insulin resistance in Mexican and U.S. Pima Indians with normal glucose tolerance. J. Clin. Endocrinol. Metab. 2010, 95, E358-E362.
108. Schulz, L.O. Bennett, P.H. Ravussin, E. Kidd, J.R. Kidd, K.K. Esparza, J. Valencia, M.E. Effects of traditional and western environments on prevalence of type 2 diabetes in Pima indians in Mexico and the U.S. Diabetes Care 2006, 29, 1866-1871.
109. Luan, J. Browne, P.O. Harding, A.H. Halsall, D.J. O'Rahilly, S. Chatterjee, V.K. Wareham, N.J. Evidence for gene-nutrient interaction at the PPARgamma locus. Diabetes 2001, 50, 686-689.
110. Scacchi, R. Pinto, A. Rickards, O. Pacella, A. de Stefano, G.F. Cannella, C. Corbo, R.M. An analysis of peroxisome proliferator-activated receptor gamma (PPAR-γ2) Pro12Ala polymorphism distribution and prevalence of type 2 diabetes mellitus (T2DM) in world populations in relation to dietary habits. Nutr. Metab. Cardiovasc. Dis. 2007, 17, 632-641.
111. Robitaille, J. Gaudet, D. Perusse, L. Vohl, M.C. Features of the metabolic syndrome are modulated by an interaction between the peroxisome proliferator-activated receptor-delta -87T>C polymorphism and dietary fat in French-Canadians. Int. J. Obes. (Lond.) 2007, 31, 411-417.
112. Delgado-Lista, J. Perez-Martinez, P. Garcia-Rios, A. Phillips, C.M. Williams, C.M. Gulseth, H.L. Helal, O. Blaak, E.E. Kiec-Wilk, B., Basu, S. et al. Pleiotropic effects of TCF7L2 gene variants and its modulation in the metabolic syndrome: From the lipgene study. Atherosclerosis 2011, 214, 110-116.
113. Lee, H.J. Kim, I.K. Kang, J.H. Ahn, Y. Han, B.G. Lee, J.Y. Song, J. Effects of common FTO gene variants associated with BMI on dietary intake and physical activity in Koreans. Clin. Chim. Acta 2010, 411, 1716-1722.
114. Sonestedt, E. Roos, C. Gullberg, B. Ericson, U. Wirfalt, E. Orho-Melander, M. Fat and carbohydrate intake modify the association between genetic variation in the fto genotype and obesity. Am. J. Clin. Nutr. 2009, 90, 1418-1425.
115. Moleres, A. Ochoa, M.C. Rendo-Urteaga, T. Martinez-Gonzalez, M.A. Azcona San Julian, M.C. Martinez, J.A. Marti, A. Dietary fatty acid distribution modifies obesity risk linked to the rs9939609 polymorphism of the fat mass and obesity-associated gene in a Spanish case-control study of children. Br. J. Nutr. 2012, 107, 533-538.
116. Garcia-Rios, A. Perez-Martinez, P. Delgado-Lista, J. Phillips, C.M. Gjelstad, I.M. Wright, J.W. Karlstrom, B. Kiec-Wilk, B. van Hees, A.M., Helal, O. et al. A Period 2 genetic variant interacts with plasma SFA to modify plasma lipid concentrations in adults with metabolic syndrome. J. Nutr. 2012, 142, 1213-1218.
117. Corella, D. Arnett, D.K. Tucker, K.L. Kabagambe, E.K. Tsai, M. Parnell, L.D. Lai, C.Q. Lee, Y.C. Warodomwichit, D., Hopkins, P.N. et al. A high intake of saturated fatty acids strengthens the association between the fat mass and obesity-associated gene and bmi. J. Nutr. 2011, 141, 2219-2225.
118. Gutierrez-Aguilar, R. Kim, D.H. Woods, S.C. Seeley, R.J. Expression of new loci associated with obesity in diet-induced obese rats: From genetics to physiology. Obesity (Silver Spring) 2011, 20, 306-312.
119. Coleman, R.A. Lewin, T.M. Muoio, D.M. Physiological and nutritional regulation of enzymes of triacylglycerol synthesis. Annu. Rev. Nutr. 2000, 20, 77-103.
120. McGarry, J.D. Banting lecture 2001: Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 2002, 51, 7-18.
121. Shimabukuro, M. Zhou, Y.T. Levi, M. Unger, R.H. Fatty acid-induced beta cell apoptosis: A link between obesity and diabetes. Proc. Natl. Acad. Sci. USA 1998, 95, 2498-2502.
122. Garcia-Rios, A. Perez-Martinez, P. Delgado-Lista, J. Lopez-Miranda, J., Perez-Jimenez, F. Nutrigenetics of the lipoprotein metabolism. Mol. Nutr. Food Res. 2012, 56, 171-183.
123. Perez-Martinez, P. Garcia-Rios, A. Delgado-Lista, J. Perez-Jimenez, F. Lopez-Miranda, J. Nutrigenetics of the postprandial lipoprotein metabolism: Evidences from human intervention studies. Curr. Vasc. Pharmacol. 2011, 9, 287-291.
124. Warodomwichit, D. Shen, J. Arnett, D.K. Tsai, M.Y. Kabagambe, E.K. Peacock, J.M. Hixson, J.E. Straka, R.J. Province, M.A. An, P. et al. ADIPOQ polymorphisms, monounsaturated fatty acids, and obesity risk: The GOLDN study. Obesity (Silver Spring) 2009, 17, 510-517.
125. Perez-Martinez, P. Lopez-Miranda, J. Cruz-Teno, C. Delgado-Lista, J. Jimenez-Gomez, Y. Fernandez, J.M. Gomez, M.J. Marin, C. Perez-Jimenez, F. Ordovas, J.M. Adiponectin gene variants are associated with insulin sensitivity in response to dietary fat consumption in Caucasian men. J. Nutr. 2008, 138, 1609-1614.
126. Ferguson, J.F. Phillips, C.M. Tierney, A.C. Perez-Martinez, P. Defoort, C. Helal, O. Lairon, D. Planells, R. Shaw, D.I. Lovegrove, J.A. et al. Gene-nutrient interactions in the metabolic syndrome: Single nucleotide polymorphisms in ADIPOQ and ADIPOR1 interact with plasma saturated fatty acids to modulate insulin resistance. Am. J. Clin. Nutr. 2010, 91, 794-801.
127. Shi, H. Kokoeva, M.V. Inouye, K. Tzameli, I. Yin, H. Flier, J.S. TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Invest. 2006, 116, 3015-3025.
128. Zhao, A. Yu, J. Lew, J.L. Huang, L. Wright, S.D. Cui, J. Polyunsaturated fatty acids are FXR ligands and differentially regulate expression of FXR targets. DNA Cell Biol. 2004, 23, 519-526.
129. Fraga, M.F. Ballestar, E. Paz, M.F. Ropero, S. Setien, F. Ballestar, M.L. Heine-Suner, D. Cigudosa, J.C. Urioste, M. Benitez, J. et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc. Natl. Acad. Sci. USA 2005, 102, 10604-10609.
130. Greco, L. Romino, R. Coto, I. Di Cosmo, N. Percopo, S. Maglio, M. Paparo, F. Gasperi, V. Limongelli, M.G. Cotichini, R. et al. The first large population based twin study of coeliac disease. Gut 2002, 50, 624-628.
131. Arkadianos, I. Valdes, A.M. Marinos, E. Florou, A. Gill, R.D. Grimaldi, K.A. Improved weight management using genetic information to personalize a calorie controlled diet. Nutr. J. 2007, 6, 29.
132. Tapueru-French, C. Can the Use of Genetics Benefit Weight Loss IN A New Zealand Setting? M.Sc. Thesis, University of Auckland, Auckland, New Zealand, 2009.
133. Stewart-Knox, B.J. Bunting, B.P. Gilpin, S. Parr, H.J. Pinhao, S. Strain, J.J. de Almeida, M.D. Gibney, M. Attitudes toward genetic testing and personalised nutrition in a representative sample of European consumers. Br. J. Nutr. 2009, 101, 982-989.